Cargando…

Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?

Detalles Bibliográficos
Autores principales: Jehle, Alexander B, Xu, Yaqin, DiMaria, Joseph D, Epstein, Frederick H, French, Brent A, Roy, R Jack, Carey, Robert M, Kramer, Christopher M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853848/
http://dx.doi.org/10.1186/1532-429X-11-S1-P29
_version_ 1783646041745129472
author Jehle, Alexander B
Xu, Yaqin
DiMaria, Joseph D
Epstein, Frederick H
French, Brent A
Roy, R Jack
Carey, Robert M
Kramer, Christopher M
author_facet Jehle, Alexander B
Xu, Yaqin
DiMaria, Joseph D
Epstein, Frederick H
French, Brent A
Roy, R Jack
Carey, Robert M
Kramer, Christopher M
author_sort Jehle, Alexander B
collection PubMed
description
format Online
Article
Text
id pubmed-7853848
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78538482021-02-04 Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling? Jehle, Alexander B Xu, Yaqin DiMaria, Joseph D Epstein, Frederick H French, Brent A Roy, R Jack Carey, Robert M Kramer, Christopher M J Cardiovasc Magn Reson Poster Presentation BioMed Central 2009-01-28 /pmc/articles/PMC7853848/ http://dx.doi.org/10.1186/1532-429X-11-S1-P29 Text en © Jehle et al; licensee BioMed Central Ltd. 2009, This article is published under license to BioMed Central Ltd. Open AccessThis article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Jehle, Alexander B
Xu, Yaqin
DiMaria, Joseph D
Epstein, Frederick H
French, Brent A
Roy, R Jack
Carey, Robert M
Kramer, Christopher M
Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?
title Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?
title_full Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?
title_fullStr Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?
title_full_unstemmed Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?
title_short Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?
title_sort does a selective non-peptide angiotensin ii type 2 receptor agonist reduce post-infarction left ventricular remodeling?
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853848/
http://dx.doi.org/10.1186/1532-429X-11-S1-P29
work_keys_str_mv AT jehlealexanderb doesaselectivenonpeptideangiotensiniitype2receptoragonistreducepostinfarctionleftventricularremodeling
AT xuyaqin doesaselectivenonpeptideangiotensiniitype2receptoragonistreducepostinfarctionleftventricularremodeling
AT dimariajosephd doesaselectivenonpeptideangiotensiniitype2receptoragonistreducepostinfarctionleftventricularremodeling
AT epsteinfrederickh doesaselectivenonpeptideangiotensiniitype2receptoragonistreducepostinfarctionleftventricularremodeling
AT frenchbrenta doesaselectivenonpeptideangiotensiniitype2receptoragonistreducepostinfarctionleftventricularremodeling
AT royrjack doesaselectivenonpeptideangiotensiniitype2receptoragonistreducepostinfarctionleftventricularremodeling
AT careyrobertm doesaselectivenonpeptideangiotensiniitype2receptoragonistreducepostinfarctionleftventricularremodeling
AT kramerchristopherm doesaselectivenonpeptideangiotensiniitype2receptoragonistreducepostinfarctionleftventricularremodeling